{"id":"https://openalex.org/W2984580366","doi":"https://doi.org/10.1182/blood-2019-123107","title":"Mitapivat (AG-348) in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused: A Phase 3, Open-Label, Multicenter, Study (ACTIVATE-T) in Progress","display_name":"Mitapivat (AG-348) in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused: A Phase 3, Open-Label, Multicenter, Study (ACTIVATE-T) in Progress","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2984580366","doi":"https://doi.org/10.1182/blood-2019-123107","mag":"2984580366"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-123107","doi":"https://doi.org/10.1182/blood-2019-123107","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123107","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Megan Lynch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Lynch","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109462199","display_name":"Lei Hua","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Hua","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042570424","display_name":"Chris Mix","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092565","display_name":"Agios Pharmaceuticals (United States)","ror":"https://ror.org/002x06r10","country_code":"US","type":"company","lineage":["https://openalex.org/I4210092565"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Mix","raw_affiliation_strings":["Agios Pharmaceuticals, Inc., Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agios Pharmaceuticals, Inc., Cambridge, MA","institution_ids":["https://openalex.org/I4210092565"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049244658","display_name":"John B. Porter","orcid":"https://orcid.org/0000-0003-3000-9359","observed_orcids":["https://orcid.org/0000-0003-3000-9359"]},"institutions":[{"id":"https://openalex.org/I1289784979","display_name":"University College Hospital","ror":"https://ror.org/00wrevg56","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289784979","https://openalex.org/I1340918713"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John B. Porter","raw_affiliation_strings":["University College London Hospitals, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London Hospitals, London, United Kingdom","institution_ids":["https://openalex.org/I1289784979"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"3526","last_page":"3526"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.95169997215271,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12286","display_name":"Erythrocyte Function and Pathophysiology","score":0.011599999852478504,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12068","display_name":"Neonatal Health and Biochemistry","score":0.010099999606609344,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mitapivat","display_name":"mitapivat","score":0.9139999747276306},{"id":"https://openalex.org/keywords/pyruvate-kinase-deficiency","display_name":"pyruvate kinase deficiency","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pklr","display_name":"PKLR gene","score":0.5950000286102295},{"id":"https://openalex.org/keywords/allosteric-activators","display_name":"allosteric activators","score":0.7509999871253967},{"id":"https://openalex.org/keywords/hemolytic-anemia","display_name":"hemolytic anemia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/regular-blood-transfusion","display_name":"regular blood transfusion","score":0.6819999814033508},{"id":"https://openalex.org/keywords/hemoglobin-response","display_name":"hemoglobin response","score":0.4909999966621399},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.43700000643730164},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.47999998927116394}],"concepts":[{"id":"https://openalex.org/C2780644154","wikidata":"https://www.wikidata.org/wiki/Q3043149","display_name":"Pyruvate kinase deficiency","level":5,"score":0.9060586094856262},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7025461792945862},{"id":"https://openalex.org/C75563809","wikidata":"https://www.wikidata.org/wiki/Q2656896","display_name":"Missense mutation","level":4,"score":0.5266385078430176},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.5070240497589111},{"id":"https://openalex.org/C2780854706","wikidata":"https://www.wikidata.org/wiki/Q900970","display_name":"Pyruvate kinase","level":4,"score":0.5048456788063049},{"id":"https://openalex.org/C2776175824","wikidata":"https://www.wikidata.org/wiki/Q1145668","display_name":"Hemolytic anemia","level":2,"score":0.44620364904403687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4440458118915558},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.21343785524368286},{"id":"https://openalex.org/C20251656","wikidata":"https://www.wikidata.org/wiki/Q162643","display_name":"Glycolysis","level":3,"score":0.17064455151557922},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14450415968894958},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11261734366416931},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07471165060997009},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-123107","doi":"https://doi.org/10.1182/blood-2019-123107","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-123107","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2986770844","https://openalex.org/W2988313448","https://openalex.org/W3211546461","https://openalex.org/W4310163499","https://openalex.org/W4310163462","https://openalex.org/W4296932772","https://openalex.org/W4310167592","https://openalex.org/W4283386868","https://openalex.org/W4283377189","https://openalex.org/W4388902254"],"abstract_inverted_index":{"Background:":[0],"Pyruvate":[1],"kinase":[2],"(PK)":[3],"deficiency":[4,80],"is":[5,42,192,216,289,394,476],"an":[6,175,255,273,456],"under-recognized":[7],"hereditary":[8],"disease":[9],"that":[10],"causes":[11],"lifelong":[12],"hemolytic":[13],"anemia.":[14],"Mutations":[15],"in":[16,30,76,187,207,222,246,266,403,412,455,461],"the":[17,56,65,131,161,201,223,231,240,267,285,305,334,353,369,395,413,422,426,431,447,451],"PKLR":[18,145,247],"gene":[19],"lead":[20],"to":[21,199,341,348,436,453,470],"reduced":[22],"red":[23,37,416],"cell":[24,418],"PK":[25,62,67,79,188,212],"(PK-R)":[26],"enzyme":[27],"activity,":[28],"resulting":[29],"defective":[31],"glycolysis":[32],"and":[33,97,139,167,180,203,298,345],"decreased":[34],"lifespan":[35],"of":[36,50,108,114,124,160,205,242,259,324,336,397,410,415,425],"blood":[38,417],"cells.":[39],"Mitapivat":[40],"(AG-348)":[41],"a":[43,70,119,193,293,299,322,401,408],"novel,":[44],"first-in-class,":[45],"oral,":[46],"small-molecule":[47],"allosteric":[48],"activator":[49],"PK-R":[51],"under":[52],"clinical":[53,156],"testing":[54],"as":[55,218,251,407],"first":[57],"targeted,":[58],"disease-altering":[59],"therapy":[60],"for":[61,91,230,365,468],"deficiency.":[63,189,213],"In":[64,352],"DRIVE":[66],"study":[68,166,170,197,271,448,459],"(NCT02476916;":[69],"phase":[71,154,163],"2,":[72],"open-label,":[73],"dose-ranging":[74],"trial":[75,185,475],"adults":[77,210],"with":[78,89,174,211,254,430],"who":[81,227,399,445],"are":[82,171,228],"not":[83],"regularly":[84,208],"transfused),":[85],"twice-daily":[86],"(BID)":[87],"dosing":[88],"mitapivat":[90,151,206,314,360,467],">6":[92],"months":[93],"was":[94,136],"well":[95],"tolerated":[96],"induced":[98],"rapid,":[99],"durable":[100],"responses":[101],"(Grace":[102],"et":[103],"al.":[104],"ASH":[105],"2017).":[106],"As":[107],"July":[109],"14,":[110],"2017,":[111],"26":[112,129],"(50%)":[113],"52":[115,287],"enrolled":[116],"subjects":[117,253,318,371,398,444],"had":[118,142],"maximum":[120,133],"hemoglobin":[121],"(Hb)":[122],"increase":[123,135],">1":[125],"g/dL.":[126],"Among":[127],"these":[128,149],"subjects,":[130],"mean":[132],"Hb":[134,377],"3.4":[137],"g/dL,":[138],"25":[140],"(96%)":[141],"\u22651":[143],"missense":[144,244],"mutation.":[146],"Based":[147],"on":[148,177,184,321],"findings,":[150],"has":[152],"entered":[153],"3":[155,164,264],"development.":[157],"The":[158,270,391,473],"design":[159],"ongoing":[162],"ACTIVATE-T":[165,191,474],"its":[168],"extension":[169,458],"reported":[172],"here,":[173],"update":[176],"country/site":[178],"activation":[179],"key":[181],"early":[182],"learnings":[183],"logistics":[186],"Methods:":[190],"global,":[194],"multicenter,":[195],"open-label":[196,457],"(NCT03559699)":[198],"evaluate":[200],"efficacy":[202],"safety":[204],"transfused":[209,215,374,420],"Regularly":[214],"defined":[217,406],"\u22656":[219],"transfusion":[220,257,282,384,389,404,433],"episodes":[221],"previous":[224,268],"year.":[225,269],"Subjects":[226],"homozygous":[229],"R479H":[232],"mutation":[233],"or":[234,379],"have":[235,450],"2":[236],"non-missense":[237],"mutations":[238],"(without":[239],"presence":[241],"another":[243],"mutation)":[245],"will":[248,252,311,319,358,372,449,465],"be":[249,330,373],"excluded,":[250],"average":[256],"frequency":[258],"more":[260],"than":[261],"once":[262],"every":[263],"weeks":[265,288,338,424],"comprises":[272],"8-week":[274],"screening":[275],"period,":[276,308,355],"during":[277,421],"which":[278,328,462],"each":[279,309,356],"subject's":[280],"complete":[281,446],"history":[283],"from":[284,346,387],"prior":[286],"documented,":[290],"followed":[291],"by":[292],"16-week":[294],"dose":[295,306,315,323,364],"optimization":[296,307],"period":[297,302,428],"24-week":[300],"fixed-dose":[301,354,427],"(Figure).":[303],"During":[304,368],"subject":[310,357],"undergo":[312],"individualized":[313],"optimization.":[316],"All":[317,443],"start":[320],"5":[325,340],"mg":[326,343,350],"BID,":[327],"may":[329],"increased":[331],"twice":[332],"over":[333],"course":[335],"16":[337],"(from":[339],"20":[342,347],"BID":[344],"50":[349],"BID).":[351],"receive":[359,466],"at":[361],"their":[362,376,382,388],"optimized":[363],"24":[366,423,437],"weeks.":[367,438,472],"study,":[370],"when":[375],"reaches":[378],"falls":[380],"below":[381],"individual":[383],"trigger":[385],"calculated":[386],"history.":[390],"primary":[392],"endpoint":[393],"proportion":[396],"achieve":[400],"reduction":[402,409],"burden,":[405],"\u226533%":[411],"number":[414],"units":[419],"compared":[429],"historical":[432],"burden":[434],"standardized":[435],"Secondary":[439],"endpoints":[440],"include":[441],"safety.":[442],"opportunity":[452],"enroll":[454],"(NCT03853798)":[460],"all":[463],"participants":[464],"up":[469],"192":[471],"enrolling":[477],"globally.":[478],"Disclosures":[479],"Lynch:":[480],"Agios:":[481,512],"Employment,":[482,488,492],"Equity":[483,489,493],"Ownership.":[484,490,494],"Hua:Agios":[485],"Pharmaceuticals,":[486],"Inc.:":[487],"Mix:Agios:":[491],"Porter:Bluebird":[495],"bio:":[496],"Consultancy,":[497,510,513],"Honoraria;":[498,501,503,506,508,511],"Silence":[499],"therapeutics:":[500],"Vifor:":[502],"La":[504],"Jolla:":[505],"Protagonism:":[507],"Celgene:":[509],"Honoraria.":[514]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-11-22T00:00:00"}